Table 4.
Common KEGG pathways for the down-regulated miRNAs.
| KEGG pathway | P-value |
|---|---|
| Hepatitis B (hsa05161) | <0.0001 |
| Proteoglycans in cancer (hsa05205) | <0.0001 |
| Glioma (hsa05214) | <0.0001 |
| Chronic myeloid leukemia (hsa05220) | <0.0001 |
| Viral carcinogenesis (hsa05203) | <0.0001 |
| Renal cell carcinoma (hsa05211) | <0.0001 |
| Bacterial invasion of epithelial cells (hsa05100) | <0.0001 |
| Pancreatic cancer (hsa05212) | <0.0001 |
| Bladder cancer (hsa05219) | <0.0001 |
| Prostate cancer (hsa05215) | <0.0001 |
| Colorectal cancer (hsa05210) | <0.0001 |
| Non-small cell lung cancer (hsa05223) | <0.0001 |
| Endometrial cancer (hsa05213) | 0.00022 |
| Melanoma (hsa05218) | 0.00024 |
| Small cell lung cancer (hsa05222) | 0.00035 |
| Thyroid cancer (hsa05216) | 0.0011 |
| Acute myeloid leukemia (hsa05221) | 0.0029 |
| Hepatitis C (hsa05160) | 0.0037 |
| HTLV-I infection (hsa05166) | 0.044 |